BioMarin Pharmaceutical, Inc. (NASDAQ:BMRN)

CAPS Rating: 3 out of 5

The Company develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.

Recs

0
Player Avatar lewrose (86.86) Submitted: 12/23/2012 1:40:21 PM : Outperform Start Price: $48.92 BMRN Score: +1.44

Tremendous pipeline of orphan drug candidates

Featured Broker Partners


Advertisement